Trans-intra-arterial gemcitabine versus continuation of IV gemcitabine and nab-paclitaxel following radiotherapy for locally advanced pancreatic cancer (TIGeR-PaC). Article

Full Text via DOI: 10.1200/JCO.2018.36.4_suppl.TPS529 Web of Science: 000436174100509

Cited authors

  • Pishvaian, Michael J.; Goodman, Karyn A.; Zervos, Emmanuel E.; Muscarella, Peter; Kim, Alexander Y.; Bloomston, Mark; Nutting, Charles W.; Meredith, Ken Lee; Lavu, Harish; Chuy, Jennifer W.; Lee, Justin; Matrana, Marc Ryan; Lavarias, Clifford; Gellert, Scott; Agah, Ramtin

Authors

Publication date

  • 2018

Published in

International Standard Serial Number (ISSN)

  • 0732-183X

Volume

  • 36

Issue

  • 4